Ubs Asset Management Americas Inc Veru Inc. Transaction History

Ubs Asset Management Americas Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$1.16 - $6.41 $50,949 - $281,540	43,922 Added 54.39%	124,669 $144,000
Q4 2022 Feb 14, 2023	BUY	$4.78 - $15.01 $35,271 - $110,758	7,379 Added 10.06%	80,747 $426,000
Q3 2022 Nov 14, 2022	BUY	$10.22 - $23.7 $129,242 - $299,710	12,646 Added 20.83%	73,368 $845,000
Q2 2022 Aug 12, 2022	BUY	$4.35 - $15.85 $1,718 - $6,260	395 Added 0.65%	60,722 $686,000
Q1 2022 May 16, 2022	BUY	$4.55 - $6.41 $1,233 - $1,737	271 Added 0.45%	60,327 $291,000
Q4 2021 Feb 14, 2022	BUY	$5.89 - $9.73 $11,815 - $19,518	2,006 Added 3.46%	60,056 $353,000
Q3 2021 Nov 15, 2021	BUY	$6.78 - $9.89 $110,290 - $160,880	16,267 Added 38.93%	58,050 $495,000
Q2 2021 Aug 16, 2021	BUY	$7.24 - $11.2 $302,508 - $467,969	41,783 New	41,783 $337,000

123

56.9M

668K

531K

Ticker VERU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,146,704
Market Cap $53.7M
Description
Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

Stay updated on Ubs Asset Management Americas Inc with notifications on news.